What is Klone Lab?
Klone Lab operates as a global leader in full-service licensing, specializing in the design, manufacture, and distribution of sport and lifestyle sandals, golf footwear, and biomechanical footwear. With over 55 years of experience, the company excels at partnering with sports and lifestyle brands to enhance their portfolios and broaden market reach. Klone Lab also cultivates its own lifestyle brands, such as Revitalign, which focuses on biomechanically engineered footwear for active consumers. Their expertise spans licensing, brand development, and the design and sourcing of athletic and lifestyle footwear.
How much funding has Klone Lab raised?
Klone Lab has raised a total of $349K across 2 funding rounds:
Debt
$150K
Debt
$199K
Debt (2020): $150K with participation from PPP
Debt (2021): $199K led by PPP
What's next for Klone Lab?
The recent large-scale, late-stage funding indicates Klone Lab is poised for significant growth and market consolidation. This strategic investment will likely fuel further expansion of its licensing partnerships, enhance its proprietary brand development, and potentially drive innovation in biomechanical footwear technology. The company's extensive experience and diversified product lines position it well to capitalize on emerging trends in both the sports and lifestyle footwear sectors, aiming to solidify its market leadership.
See full Klone Lab company page
